This key regulatory approval enables Trinity Biotech to transition upstream production from its legacy in-house operations to a more cost-effective and scalable outsourced model, while maintaining ...

Get the latest Trinity Biotech plc (TRIB) stock news and headlines to help you in your trading and investing decisions.

This key regulatory approval enables Trinity Biotech to transition upstream production from its legacy in-house operations to a more cost-effective and scalable outsourced model, while maintaining the ...

Trinity Biotech sells direct in the United States and through a network of international distributors and strategic partners in over 75 countries worldwide.

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), currently trading at $0.55 per share with a market capitalization of approximately $10 million, has received World Health Organization approval for ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), currently trading at $0.55 per share with a market capitalization of approximately $10 million, has received World Health Organization approval for ...

Trinity Biotech claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms “may,” ...

Get the latest Trinity Biotech plc (TRIB) stock news and headlines to help you in your trading and investing decisions.

View the latest Trinity Biotech PLC ADR (TRIB) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Trinity Biotech Plc is listed on the CBOE trading with ticker code TRIB.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year, Trinity Biotech Plc ...